Advanced Filters
noise
Found 64,920 clinical trials
K Kamel LARIBI, MD

Observatory of Prolymphocytic Leukemia T

Prolymphocytic leukemia T is a rare disease representing approximately 2% of mature lymphoid leukemias and 20% of prolymphocytic leukemias. It mainly affects the elderly with an aggressive clinical course. It is a hemopathy exhibiting a post thymic T phenotype (Tdt-, CD1a-, CD5 +, CD2 + and CD7 +), generally CD4 …

18 years of age All Phase N/A
P Peter Kirrander, MD PhD

Lymphedema After Urologic Surgery

Lymphedema of the extremities is common after lymph node surgery in treating several forms of cancer, e.g., breast cancer. However, very little is known of the occurrence of lymphedema of the lower extremities after urologic surgery with lymph node dissection. This project aims to describe the frequency and grade of …

18 years of age All Phase N/A
J Jeannine Heckmann, MD

Phenotype, Genotype and Biomarkers 2

The purpose of this study is to learn more about amyotrophic lateral sclerosis (ALS) and other related neurodegenerative diseases, including frontotemporal dementia (FTD), primary lateral sclerosis (PLS), hereditary spastic paraplegia (HSP), progressive muscular atrophy (PMA) and multisystem proteinopathy (MSP). More precisely, the investigator wants to identify the links that exist …

7 years of age All Phase N/A
A Alexander Oberhuber, MD Phd

Outcome of a Triple Inner Branched Aortic Arch Stentgraft. A Prospective, Multicenter Registry.

Outcome of a triple inner branched aortic arch stentgraft. A prospective, mulitcenter registry.

years of age All Phase N/A
S Sofie Rutsaert

HIV Study on MEasuring the Reservoir on Cellular Level to CUre Infection

The aim of this study is to gain new insights into HIV latency and reversal through extensive blood and tissues sampling (lymph node and colon biopsies) from 25 individuals under ART.

18 - 65 years of age All Phase N/A
M Marian Kerbleski, RN

The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

HIV medicines have led to dramatic improvements in health. However, there remains a concern for potential drug toxicities, cost of drugs, and need for life-long treatment. In addition, research has found that health is not completely restored in HIV-infected patients, even if they have been taking effective HIV medicines for …

18 - 70 years of age All Phase N/A
I Isabelle Brindel

Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support

Bone marrow transplantation is both a great treatment for patients with hematological diseases. It is also one of the only hopes of staying alive by "starting from scratch". It is a trying life experience, at all its stages. To support these patients and increase their success in healing and returning …

18 years of age All Phase N/A
G Gianluca Costa, MD, PhD

Gastrointestinal Emergency Surgery: Evaluation of Morbidity and Mortality

Gastrointestinal Emergency Surgery: Evaluation of Morbidity and Mortality

18 years of age All Phase N/A
B Brianna Aponte

Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer

This study is an observational study of blood and tissue biomarkers. Investigators plan to evaluate the accuracy of lung cancer biomarkers found in the blood in determining if a lung nodule is cancer or benign. Investigators also plan to examine another biomarker found in the tumor tissue to identify participants …

18 years of age All Phase N/A
C Chun-Fu Lai, M.D.

Preference of Life-Sustaining Treatment Among Patients With End Stage Renal Disease

Although patients with kidney disease can rely on dialysis to prolong their lives, the complexity of the disease, the variability of the course of the disease, and the uncertainty of the prognosis often delay the discussion of issues at the end of life, and the deterioration of the condition often …

20 years of age All Phase N/A

Simplify language using AI